157 related articles for article (PubMed ID: 32412789)
1. High Expression of Asparagine Synthetase Is Associated with Poor Prognosis of Breast Cancer in Chinese Population.
Qin C; Yang X; Zhan Z
Cancer Biother Radiopharm; 2020 Oct; 35(8):581-585. PubMed ID: 32412789
[No Abstract] [Full Text] [Related]
2. Elevated Expression of RIOK1 Is Correlated with Breast Cancer Hormone Receptor Status and Promotes Cancer Progression.
Huang Z; Li X; Xie T; Gu C; Ni K; Yin Q; Cao X; Zhang C
Cancer Res Treat; 2020 Oct; 52(4):1067-1083. PubMed ID: 32599985
[TBL] [Abstract][Full Text] [Related]
3. MiR-940 promotes malignant progression of breast cancer by regulating FOXO3.
Zhang H; Peng J; Lai J; Liu H; Zhang Z; Li X; Liang B; Chen X; Zou B; Lin S; Zhang L
Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32840296
[TBL] [Abstract][Full Text] [Related]
4. High methionyl-tRNA synthetase expression predicts poor prognosis in patients with breast cancer.
Jin Q; Liu G; Wang B; Li S; Ni K; Wang C; Ren J; Zhang S; Dai Y
J Clin Pathol; 2020 Dec; 73(12):803-812. PubMed ID: 32404475
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA LINC00473 indicates a poor prognosis of breast cancer and accelerates tumor carcinogenesis by competing endogenous sponging miR-497.
Bai J; Zhao WY; Li WJ; Ying ZW; Jiang DQ
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3410-3420. PubMed ID: 31081095
[TBL] [Abstract][Full Text] [Related]
6. CYP27A1 expression is associated with risk of late lethal estrogen receptor-positive breast cancer in postmenopausal patients.
Kimbung S; Inasu M; Stålhammar T; Nodin B; Elebro K; Tryggvadottir H; Ygland Rödström M; Jirström K; Isaksson K; Jernström H; Borgquist S
Breast Cancer Res; 2020 Nov; 22(1):123. PubMed ID: 33176848
[TBL] [Abstract][Full Text] [Related]
7. miR‑425‑5p is associated with poor prognosis in patients with breast cancer and promotes cancer cell progression by targeting PTEN.
Xiao S; Zhu H; Luo J; Wu Z; Xie M
Oncol Rep; 2019 Dec; 42(6):2550-2560. PubMed ID: 31638259
[TBL] [Abstract][Full Text] [Related]
8. Expression of microRNA-497 and its prognostic significance in human breast cancer.
Wang S; Li H; Wang J; Wang D
Diagn Pathol; 2013 Oct; 8():172. PubMed ID: 24143964
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-296 functions as a tumor suppressor in breast cancer by targeting FGFR1 and regulating the Wnt/β-catenin signaling pathway.
Sun WM; Tao W; Li JC; Zhu DM; Miao Y
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10422-10432. PubMed ID: 31841196
[TBL] [Abstract][Full Text] [Related]
10. Elevated MMP9 expression in breast cancer is a predictor of shorter patient survival.
Joseph C; Alsaleem M; Orah N; Narasimha PL; Miligy IM; Kurozumi S; Ellis IO; Mongan NP; Green AR; Rakha EA
Breast Cancer Res Treat; 2020 Jul; 182(2):267-282. PubMed ID: 32445177
[TBL] [Abstract][Full Text] [Related]
11. NEDD4 expression is associated with breast cancer progression and is predictive of a poor prognosis.
Wan L; Liu T; Hong Z; Pan Y; Sizemore ST; Zhang J; Ma Z
Breast Cancer Res; 2019 Dec; 21(1):148. PubMed ID: 31856858
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of asparagine synthetase (ASNS) suppresses cell proliferation and inhibits tumor growth in gastric cancer cells.
Yu Q; Wang X; Wang L; Zheng J; Wang J; Wang B
Scand J Gastroenterol; 2016 Oct; 51(10):1220-6. PubMed ID: 27251594
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of long non-coding RNA CCAT1 is a novel biomarker of poor prognosis in patients with breast cancer.
Zhang XF; Liu T; Li Y; Li S
Int J Clin Exp Pathol; 2015; 8(8):9440-5. PubMed ID: 26464701
[TBL] [Abstract][Full Text] [Related]
14. Asparagine Synthetase Is Highly Expressed at Baseline in the Pancreas Through Heightened PERK Signaling.
Mukherjee A; Ahmed N; Rose FT; Ahmad AN; Javed TA; Wen L; Bottino R; Xiao X; Kilberg MS; Husain SZ
Cell Mol Gastroenterol Hepatol; 2020; 9(1):1-13. PubMed ID: 31421261
[TBL] [Abstract][Full Text] [Related]
15. Breast Cancer Survival Defined by Biological Receptor and Menopausal Status in Vietnamese Women.
Vu Hong T; Nguyen Ba D; Skoog L; Ta Thanh V; Tani E
Cancer Control; 2019; 26(1):1073274819865279. PubMed ID: 31343899
[TBL] [Abstract][Full Text] [Related]
16. Increased long noncoding RNA LINP1 expression and its prognostic significance in human breast cancer.
Liu XM; Yang B; Han J
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8749-8754. PubMed ID: 30575915
[TBL] [Abstract][Full Text] [Related]
17. Expression of LPA2 is associated with poor prognosis in human breast cancer and regulates HIF-1α expression and breast cancer cell growth.
Li M; Xiao D; Zhang J; Qu H; Yang Y; Yan Y; Liu X; Wang J; Liu L; Wang J; Duan X
Oncol Rep; 2016 Dec; 36(6):3479-3487. PubMed ID: 27805252
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of interferon regulating factor 4 (IRF4) in node-negative breast cancer.
Heimes AS; Madjar K; Edlund K; Battista MJ; Almstedt K; Gebhard S; Foersch S; Rahnenführer J; Brenner W; Hasenburg A; Hengstler JG; Schmidt M
J Cancer Res Clin Oncol; 2017 Jul; 143(7):1123-1131. PubMed ID: 28251349
[TBL] [Abstract][Full Text] [Related]
19. An immune cell infiltration-based immune score model predicts prognosis and chemotherapy effects in breast cancer.
Sui S; An X; Xu C; Li Z; Hua Y; Huang G; Sui S; Long Q; Sui Y; Xiong Y; Ntim M; Guo W; Chen M; Deng W; Xiao X; Li M
Theranostics; 2020; 10(26):11938-11949. PubMed ID: 33204321
[No Abstract] [Full Text] [Related]
20. Association of allele-specific methylation of the ASNS gene with asparaginase sensitivity and prognosis in T-ALL.
Akahane K; Kimura S; Miyake K; Watanabe A; Kagami K; Yoshimura K; Shinohara T; Harama D; Kasai S; Goi K; Kawai T; Hata K; Kiyokawa N; Koh K; Imamura T; Horibe K; Look AT; Minegishi M; Sugita K; Takita J; Inukai T
Blood Adv; 2022 Jan; 6(1):212-224. PubMed ID: 34535013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
